Header and Body 4

Advantages

  • Effective method in inhibiting or reducing the severity of a heat shock protein (hsp)-mediated ocular neurodegenerative condition.
  • Early diagnosis and evaluation of treatment efficacy
  • Immunosuppressant agent could be administer to ocular tissue
  • Therapeutic treatment of glaucoma, anterior ischemic optic neuropathy